NEW YORK (

TheStreet

) --

Qiagen

(Nasdaq:

QGEN

) is trading at unusually high volume Monday with 5.7 million shares changing hands. It is currently at four times its average daily volume and trading up 56 cents (+3%) at $19.42 as of 2:42 p.m. ET.

Qiagen has a market cap of $4.5 billion and is part of the

health care

sector and

drugs

industry. Shares are down 3.6% year to date as of the close of trading on Friday.

QIAGEN N.V., through its subsidiaries, provides sample and assay technologies. The company has a P/E ratio of 31.5, below the average drugs industry P/E ratio of 33.2 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Qiagen as a

buy

. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. You can view the full

Qiagen Ratings Report

.

See all heavy volume stocks in our

stocks moving on unusual volume list

or get investment ideas from our

investment research center

.

Interested in other stocks that are rising on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting

HVUP

to 95370 or select from

multiple alert options

.

null